List view / Grid view
Fuelled by advances in rare disease treatments and vaccination efforts, Natalia Elizalde, CBO at VIVEbiotech, discusses how the market demand for lentiviral vectors is evolving, the new therapeutic areas emerging as potential targets for in vivo gene therapy and the latest technological advancements in the development and delivery of in…
Researchers utilised AI to identify genes that reprogramme GBM cancer cells into dendritic cells within the tumour.
In this Q&A, Erik Wiklund, CEO of Circio, explains the key findings of their circVec circular RNA platform technology, why they chose AAV-based gene therapy for AATD as the lead programme, and their plans for the future to enhance the potency and reduce the cost of current gold-standard gene therapy.
The experimental therapy eliminated 90 percent of HSV-1 after facial infection and 97 percent of HSV-1 after genital infection.
Use of the whole liver could revolutionise the development of viral vectors, providing more effective treatments for inherited diseases.
The new study suggests that this gene therapy method may combat ARVC in both early and more advanced stages of the condition.
